ReviewHIV medicine2025
Solid organ transplantation in people with HIV: Outcomes, obstacles and opportunities.
Review in HIV medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Influence of HIV Status on Organ Procurement and Allocation: A Discrete Choice Experiment of Australian Transplant Providers.Open forum infectious diseases · 2026Article
- Solid organ transplantation in people with HIV: Outcomes, obstacles and opportunities.HIV medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectivePeople with HIV experience disparate access to solid organ transplantation (SOT), despite mounting evidence for comparable outcomes. This review aims to understand the outcomes following SOT, obstacles to SOT and opportunities to improve access and outcomes following SOT.
methodsWe conducted a narrative review of the literature.
resultsSOT is safe and effective for people with HIV, and increasing evidence indicates that people with HIV may safely donate organs to others with HIV. People with HIV experience a higher risk of acute rejection following SOT, without a higher risk of graft loss or death, when compared with appropriately matched controls. Those with HIV experience systemic and structural barriers to SOT, in addition to barriers that occur at the level of healthcare providers and consumers. Opportunities exist to improve access to SOT, and to improve SOT-related care for people with HIV.
conclusionSOT should be considered standard of care for people with HIV when indicated. Further efforts are required to identify and address gaps in the SOT-related cascade of care; and to improve SOT outcomes for people with HIV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.